L-glutamate and L-aspartate bind to separate sites in rat brain synaptic membranes

Motor effects of intracaudate injection of excitatory amino acids

In a study of the role of excitatory amino acid receptors in movement disorders, the effect of the injection of glutamate (Glu), aspartate (Asp), N-methyl-D-aspartate (NMDA), quisqualate (Qu), or kainate (K) into the rat striatum was investigated. Rats were microinjected unilaterally through chronically implanted guide cannulas and their motor behavior was recorded. After 10-25 min L-Glu produced reversible periodic choreiform movements lasting 5-10 sec and contraversive rotation lasting 1-2 min. Both episodes were repeated every 2-3 min: the duration of motor effects was 60-80 min. L-Asp had an effect similar to that of L-Glu and in addition produced barrel rolling. The L-isomers of both Glu and Asp were active and the D-isomers were inactive. NMDA, Qu, and K were more potent than Glu or Asp. Each produced effects similar to that of Glu, and in addition NMDA and K produced wet-dog-shakes and masticatory movements. The motor behavior produced by Qu was identical to that of Glu, but it lasted longer. The motor effects of L-Glu were blocked by L-glutamic acid diethyl ester (GDEE) and by a larger sedative dose of 2-amino-5-phosphonopentanoic acid (AP5), but not by haloperidol, GABA, glycine (Gly), or a smaller nonsedative dose of AP5. The results suggest that the motor effects of L-Glu were produced by activation of the Qu-type (glutamatergic) receptors, not involving the dopamine and GABA systems. However, activation of the K-type receptors by L-Glu cannot be ruled out.

L-glutamate binding sites of normal and atrophic human cerebellum

The binding kinetics, pharmacologic properties, ontogeny and localization of L-glutamate binding sites were studied in membrane preparations and sections of normal and olivopontocerebellar atrophy (OPCA) human cerebellum. One binding component was found with a Kd value in the order of 150 x 10(-9) M. No significant changes of Kd values were observed with age, whereas the highest Bmax value was observed at the age of 1 year. L-Aspartate, ibotenate, quisqualate and L-homocysteic acid were potent inhibitors of L-[3H]glutamate binding. Quantitative densitometric measurements indicated the presence of L-glutamate sites in both the molecular and granule cell layer. In OPCA cerebella a very significant decrease of L-[3H]glutamate specific binding (Bmax) was observed, whereas Kd values were found unchanged. The pharmacologic properties of L-[3H]glutamate binding sites of OPCA cerebellar tissues were similar to those of normal cerebellum. [3H]quinuclidinyl benzylate binding, expressed in fmol/mg protein, did not show significant differences between normal and OPCA cerebella.

Na+-independent L-aspartate binding sites in chick brain

1. One binding component with a Kd value of 200 x 10(-9) M and half-life of the ligand binding component of 30 min was found. 2. Chloride ions produced a significant increase of L-[3H]aspartate and L-[3H]glutamate binding. 3. L-Glutamate, L-ibotenate, L-quisqualate, and DL-homocysteic acid were potent inhibitors of L-[3H]aspartate binding. 4. In all brain regions major increases of binding were observed during the third week of the in ovo period of life.

Characterisation of Na+-independent L-[3H]glutamate binding sites in human temporal cortex

The binding of L-[3H]glutamate to membranes from human temporal cortex was studied in the absence of Na+, Ca2+, and Cl- ions. Pharmacological characterisation revealed that approximately 35% of specific binding at 50 nM L-[3H]glutamate was sensitive to a combination of kainate and alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid. The remaining approximately 65% of specific binding was to a single population of sites with a KD of 844 nM and a Bmax of 0.92 pmol/mg protein. The pharmacological characteristics were consistent with an interaction at the N-methyl-D-aspartate subclass of excitatory amino acid receptor. The inclusion of Cl- ions revealed additional glutamate binding; this was sensitive to quisqualate and DL-2-amino-4-phosphonobutyrate, but not to kainate, DL-2-amino-7-phosphonoheptanoate, or alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid.

L-aspartate and L-glutamate binding sites in developing normal and 'nervous' mutant mouse cerebellum

This study concerns the ontogeny and the cellular localization of L-aspartate and L-glutamate binding sites in normal and 'nervous' mutant mouse cerebellar membranes. The binding kinetics revealed for L-aspartate a single binding system (Kd = 750 nM) and for L-glutamate also a single binding component of higher affinity (Kd = 344 nM). The pharmacological study, using various amino acid analogues, revealed a differential specificity for the binding sites of the two amino acids. The developmental study showed that the binding sites of both amino acids appear mainly during the second and third week of life, a period when parallel and climbing fiber synaptogenesis occurs, but they follow a slightly different developmental pattern. The study using 'nervous', mutant mouse cerebellum showed an age-dependent decrease of L-aspartate and L-glutamate binding, which coincides in time with the Purkinje cell degeneration in this mutant, indicating a cellular localization of these binding sites on the Purkinje cell membranes. These results suggest that L-aspartate and L-glutamate binding sites may be respectively associated with the postsynaptic target of climbing and parallel fibers on the Purkinje cell dendrites. However, the decrease of specific binding in 'nervous' mutant mouse cerebellum was about 50% for L-aspartate and 60% for L-glutamate, implying that a significant number of L-aspartate and L-glutamate binding sites are located on cerebellar elements other than the Purkinje cell membranes.

Binding sites for [3H]glutamate and [3H]aspartate in human cerebellum

The binding of [3H]aspartate and [3H]glutamate to membranes prepared from frozen human cerebellar cortex was studied. The binding sites differed in their relative proportions, their inhibition by amino acids and analogues, and by the effects of cations. A proportion (about 30%) of [3H]glutamate binding was to sites similar to those labelled by [3H]aspartate. An additional component of [3H]glutamate binding (about 50%) was displaced by quisqualate and alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid, and may represent a "quisqualate-preferring" receptor. Neither N-methyl-D-aspartic acid-sensitive nor DL-2-amino-4-phosphonobutyric acid-sensitive [3H]glutamate binding was detected.

The binding of acidic amino acids to snail, Helix aspersa, periesophagic ring membranes reveals a single high-affinity glutamate/kainate site

The characterization of specific acidic amino acid binding sites to snail, Helix aspersa, ganglia membranes has been assayed using tritiated glutamate (L-[3H]Glu), aspartate (L-[3H]Asp), cysteine sulfinate (L-[3H]CSA) and kainate. At 2 degrees C, only L-[3H]Glu and [3H]kainate specific binding could be measured using a filtration procedure to separate bound from free ligand. The analysis of L-[3H]Glu specific binding reveals the presence of one class of high-affinity binding sites with Kd = 0.12 microM and Bmax = 30 pmol/mg protein. This L-[3H]Glu binding was specific, reversible and saturable. The order of potency of different substances, agonists or antagonists of the rat brain excitatory amino acid receptors, has been determined. Kainate was the best displacing agent, followed by ibotenate = L-Glu greater than L-alpha-aminoadipate (L-alpha-AA) greater than homocysteate (HCA). Using 10 nM [3H]kainate, a single class of binding site was detected. Its pharmacological properties indicate that it is likely identical to the L-[3H]Glu binding site. This L-Glu-kainate site possesses most of the properties expected for a specific receptor. However, whereas L-[3H]Glu binding could be detected on purified neuronal membranes, the major component of specifically bound L-[3H]Glu appeared to be located on the sheaths surrounding neuronal cell bodies. These findings suggest that Glu or another endogenous acidic amino acid may function as a transmitter at neuromuscular junctions in Helix periesophagic ring, acting at a receptor distinct from those on nerve cells.

The subcellular distribution of DL-[3H]2-amino-4-phosphonobutyrate binding sites in the rat brain

The subcellular distribution of DL-[3H]2-amino-4-phosphonobutyrate binding sites in rat brain was examined. Binding sites for this radioligand, which selectively labels a chloride/calcium-dependent subpopulation of glutamate binding sites, were highly concentrated in synaptic membrane fractions. This is wholly consistent with the proposed involvement of this site in physiological responses.

Altered amino acid levels in multiply affected sibships with seizures

Evidence of genetic factors in seizure disorders by examination of plasma amino acid concentrations in multiply affected sibships was investigated. The strategy of multiply affected sibship ascertainment was used to reduce heterogeneity as one of several potential sources of variation in quantitative amino acid levels. Our results do not support previously reported increases in plasma taurine, aspartic acid, or glutamic acid in seizure patients. However, we do find that multiply affected sibships have significantly elevated plasma concentrations of arginine and asparagine, and significantly decreased ornithine. These amino acid concentrations may be under quantitative genetic control. Within-sibship comparisons indicate that seizure patients have increased glutamine and decreased lysine and phenylalanine, possibly secondary to the seizures. We also find that anticonvulsant use complicates statistical analyses. Further studies to more clearly delineate the genetics of plasma amino acid concentrations (or other quantitative metabolic measures) and their role in seizure disorders are required and will benefit from the use of a homogeneous sampling strategy.

Acidic amino acid binding sites in mammalian neuronal membranes: their characteristics and relationship to synaptic receptors

This review summarizes studies designed to label and characterize mammalian synaptic receptors for glutamate, aspartate and related acidic amino acids using in vitro ligand binding techniques. The binding properties of the 3 major ligands employed--L-[3H]glutamate, L-[3H]aspartate and [3H]kainate--are described in terms of their kinetics, the influence of ions, pharmacology, molecular nature, localization and physiological/pharmacological function. In addition, the binding characteristics are described of some new radioligands--[3H]AMPA, L-[3H]cysteine sulphinate, L-[35S]cysteate, D-[3H]aspartate, D,L-[3H]APB, D-[3H]APV and D,L-[3H]APH. Special emphasis is placed on recent findings which allow a unification of the existing binding data, and detailed comparisons are made between binding site characteristics and the known properties of the physiological/pharmacological receptors for acidic amino acids. Through these considerations, a binding site classification is suggested which differentiates 5 different sites. Four of the binding site subtypes are proposed to correspond to the individual receptor classes identified in electrophysiological experiments; thus, A1 = NMDA receptors; A2 = quisqualate receptors; A3 = kainate receptors; A4 = L-APB receptors; the fifth site is proposed to be the recognition site for a Na+-dependent acidic amino acid membrane transport process. An evaluation of investigations designed to elucidate regulatory mechanisms at acidic amino acid binding sites is made; hypotheses such as the Ca2+-activated protease hypothesis of long-term potentiation are assessed in terms of the new binding site/receptor classification scheme, and experiments are suggested which will clarify and expand this exciting area in the future.

Changes in the status of neurotransmitter receptors in a rabbit model of hepatic encephalopathy

It has previously been shown in an animal model of hepatic encephalopathy (HE) that the number of receptors for the inhibitory neurotransmitter, gamma-aminobutyric acid (GABA), increases and that the number of receptors for the excitatory neurotransmitter, glutamate, decreases. To determine the functional status of other neurotransmitter systems in HE, measurements were made of the specific binding of other neurotransmitters to synaptic membranes prepared from the brains of normal rabbits and rabbits in HE due to galactosamine-induced acute liver failure. The development of HE was associated with: (i) a decrease in the density (Bmax) of receptors for the two excitatory amino acid neurotransmitters, aspartate and kainic acid; (ii) an increase in the Bmax of both the low and high affinity binding site for strychnine, a marker for the inhibitory neurotransmitter glycine; (iii) a decrease in the affinity (Kd) of receptors for dopamine, and (iv) no appreciable change in either the specific binding of [3H]D-ala2-methionine enkephalinamide or [3H]naloxone, markers for opiate receptors, or in the Bmax or the Kd of receptors for acetylcholine. If it is assumed that the sensitivity of the brain to neurotransmitters varies directly with the density of neurotransmitter receptors, HE may be associated with increased sensitivity to inhibitory amino acid neurotransmitters and decreased sensitivity to excitatory amino acid neurotransmitters. Thus, the observed changes in neurotransmitter receptors in HE afford a feasible pathophysiological basis for the mediation of the neural inhibition of HE.

A comparative study of L[3H]-glutamate and L[3H]-cysteine sulfinate binding sites in subcellular fractions of rat brain

A comparative study of the binding of L-cysteine sulfinic acid (CSA) and L-glutamic acid (GLU) to various subcellular fractions of membranes from rat brain was made. Kinetic parameters were determined in all fractions for both types of binding. The effects of membrane preincubation, freezing, and thawing were also examined. The GLU and CSA specific binding levels increased in medium-density (C) and high-density (D) synaptic membranes as compared to the crude mitochondrial/synaptosomal membranes (wP2). Freezing and thawing reduced CSA binding in all tested subcellular fractions. GLU binding is reduced in wP2, C, and D. Binding to the "light" synaptic membranes (B) was not significantly affected, suggesting the presence of two GLU sites. Kinetics of the GLU binding indicated that the temperature-sensitive and -insensitive sites have Kd of 600 nM and 1,100/nM, respectively. Preincubation of fresh membranes conversely affected CSA and GLU binding to the various subcellular fractions, increasing CSA binding in wP2, B, C and decreasing it in D suggesting the existence of distinct sites for GLU and CSA. Preincubation of previously frozen membranes similarly modified CSA and GLU binding except in B fractions. CSA and GLU binding exhibited different pH sensitivities in both fresh and frozen membranes. These results indicate that multiple acid amino acid binding sites exist in membranes and that they can be differentiated according to their sensitivity to temperature. They also suggest the existence of distinct sites for CSA and GLU in fresh membranes, giving further support to the hypothesis that CSA may also serve a neurotransmitter role in the rat central nervous system.

L-[3H]Glutamate binding to hippocampal synaptic membranes: two binding sites discriminated by their differing affinities for quisqualate

The excitatory glutamate analogs quisqualate and ibotenate were employed to distinguish multiple binding sites for L-[3H]glutamate on freshly prepared hippocampal synaptic membranes. The fraction of bound radioligand that was displaceable by 5 microM quisqualate was termed GLU A binding. That which persisted in the presence of 5 microM quisqualate, but was displaceable by 100 microM ibotenate, was termed GLU B binding. GLU A binding equilibrated within 5 min and remained unchanged for up to 80 min. GLU B binding appeared to equilibrate at least as rapidly, but incubation with ligand unmasked latent binding sites. Saturation binding curves were best fitted by single exponentials, which yielded KD values of about 200 nM (GLU A) and 1 microM (GLU B). On the average, GLU B binding sites were about twice as abundant in these membranes as were GLU A sites. Rapid freezing of the membranes, followed by storage at -26 degrees C and rapid thawing markedly diminished GLU A binding, but nearly tripled GLU B binding. Both site bound L-glutamate with 10-30 times the affinity of D-glutamate. The GLU A site also bound L-glutamate with about 10 times the affinity of L-aspartate and discriminated poorly between L- and D-aspartate. In contrast, the GLU B site bound L-aspartate with an affinity similar to that for L-glutamate, and with an order-of-magnitude greater affinity than D-aspartate. The structural specificities of the GLU A and GLU B binding sites suggest that these sites may correspond to receptors on hippocampal pyramidal cell dendrites that are activated by iontophoretically applied L-glutamate.

Freezing eliminates a specific population of L-glutamate receptors in synaptic membranes

The binding of L-[3H]glutamate (L-Glu) to freeze-thawed synaptic membranes (SPMs) exhibited saturation kinetics, with Kd 507 nM and Bmax 6.99 pmol/mg protein. The effects of ions, the susceptibility to Triton X-100 and the pharmacological properties of the binding indicated that those sites detected in freeze-thawed SPMs were only of the Cl-/Ca2+-independent type. The Cl-/Ca2+-dependent (2-amino-4-phosphonobutyrate-sensitive) L-Glu binding sites which are additionally present in fresh SPMs are abolished by freezing.

Receptors for the excitatory amino acids in the mammalian central nervous system

On the basis largely of neuropharmacological analysis, three different receptors mediating neuronal excitation can be identified. The first is activated by quisqualate and other "flexible" molecules including L-glutamate and appears to bind its ligands in a folded configuration. The second is excited by NMDA and has a more extended conformation, the spacing between the amino and the omega-carboxylate groups being the determinant of specificity. The third type accepts kainate and appears to possess a reactive site for the unsaturated side chain which is essential to the operation of this receptor. All three classes appear to be implicated in synaptic events [although some kainate receptors at least are certainly extra-synaptic (Watkins et al., 1981)] and each appears to activate different ionophores in neuronal membranes. Of the endogenous amino acids which may function as synaptic transmitters, L-glutamate and L-cysteate seem to react preferentially with quisqualate receptors (McLennan and Lodge, 1979), while L-aspartate is more of a mixed agonist capable of reaction both with quisqualate and with the NMDA types. Whether folate has a physiological role involving kainate receptors is unknown; and the same is true of any action possessed by quinolinate. The fact that there are amino acid excitants which are pharmacologically distinct from those reacting with any of the three best known receptors suggests that at least one more class of receptor may also exist, but no further information is available at the present time. Other sites with which the pharmacologically active acidic amino acids react are identifiable neurochemically in membrane preparations derived from tissues of the central nervous system. Kinetic studies and analysis of inhibition of sodium-independent binding indicate that there are sites which accept glutamate, others binding aspartate and a third which binds kainate. However, the first does not correspond completely to the quisqualate excitatory receptor, and NMDA does not react with any of the binding sites. It is difficult to conclude then that any of these binding sites can be fully identified with the excitatory receptors. Finally, there are a number of systems which in their patterns of activity again appear completely distinct, but which presumably mediate uptake of amino acids.(ABSTRACT TRUNCATED AT 400 WORDS)

Chloride ions enhance L-glutamate binding to rat brain synaptic membranes

Chloride ions increased L-glutamate (L-Glu) binding to synaptic membranes. The binding was saturable and resulted in a 2.5-fold enhancement at concentrations of 20--40 mM chloride. Sodium and potassium ions inhibited only chloride stimulated L-Glu binding. Calcium ions also increased L-Glu binding but this was observed only in the presence of chloride. The anion selectivity of the enhancement of L-Glu binding was similar to that reported for the membrane chloride channel, suggesting that some L-Glu binding sites may be associated with this channel.

Regulation of glutamate receptors: possible role of phosphatidylserine

The polar head group of the phospholipid phosphatidylserine is similar in structure to the glutamate analogue 2-amino-4-phosphonobutyric acid (APB), an antagonist of excitatory transmission in the brain. When tested in ligand binding assays phosphatidylserine and its polar head group components O-phosphoserine and L-alpha-glycerophosphoserine were good displacers of APB-sensitive L-glutamate binding. The polar head group components were also antagonists of synaptic field potentials in the rat dentate gyrus evoked by stimulation of a presumed glutamate-using pathway. These results suggest that phosphatidylserine may regulate the activity of synaptic L-glutamate receptors.

Anticonvulsant action of excitatory amino acid antagonists

Compounds that antagonize neuronal excitation induced by dicarboxylic amino acids were tested in two animal models of epilepsy, namely sound-induced seizures in DBA/2 mice and threshold pentylenetetrazol seizures in Swiss mice. Sound-induced seizures could be prevented by intracerebroventricular injection of compounds that block excitation due to N-methyl-D-aspartic acid. The most potent such compound, 2-amino-7-phosphonoheptanoic acid, was anticonvulsant in both test systems when given either intraperitoneally or intracerebroventricularly. Specific antagonists of excitation that is caused by amino acids provide a new class of anticonvulsant agents.